Why Italian Pharmaceutical Companies Prefer Modular Aseptic Systems

The pharmaceutical market in Italy is rapidly evolving toward:

Flexible production
Smaller batch manufacturing
Faster commercialization
Multi-product operations

Large traditional filling lines are no longer ideal for many biotech companies.

Instead, manufacturers increasingly prefer:
✔ Compact systems
✔ Faster deployment
✔ Flexible manufacturing
✔ Easier scalability
✔ Lower CAPEX investment

This trend is especially strong among:

Italian biotech startups
CDMOs
Peptide manufacturers
Injectable pharmaceutical companies